By WHAV Staff |
(File photograph.)
As a public service, 97.9 WHAV presents Community Spotlight at no charge for the benefit of Greater Haverhill nonprofit organizations. To submit news of events, fundraising appeals and other community calendar announcements, Click image.
Attorney Holly Vietzke-Lynch and Jennifer Warren of Warren Advocacy are presenting a “Basic Rights Training” March 24.
The Haverhill Special Education Parent Advisory Council says the free online workshop is for all parents, guardians and caregivers of children with individual education plans or 504 plans or who think their children may have special needs.
“Basic Rights Training” takes place Wednesday, March 24, at 6 p.m. Those interested may click here to register.
Call for applications to participate in the 11th meeting of the Council of Europe Dialogue with Roma and Traveller civil society on Combating antigypsyism coe.int - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from coe.int Daily Mail and Mail on Sunday newspapers.
By John Lee Grant |
Central Plaza, 2 Water St., Haverhill. (Courtesy photograph.)
As Haverhill marks the milestone of one year since the city’s first coronavirus case, Mayor James J. Fiorentini says COVID-19 vaccines are on the way and better days lie ahead.
The mayor gave the update earlier this week before the City Council, saying that two vaccination locations are opening in Haverhill.
“The first new clinic is the Health Department Clinic which will operate out of the Citizens Center. This clinic has been assured of 600 doses of vaccine per week and they will start next week. The second site, that will be operated by Haverhill Family Health. It will be located in Central Plaza, right next to Market Basket. That site will start with 200 per day and will ramp up, hopefully, to get to 4,000 a week. That site will be open to anyone who lives or works in Haverhill or the surrounding region,” the mayor said.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
Prometheus Biosciences is taking a precision medicine approach to developing drugs and diagnostics for inflammatory bowel disease. The IPO cash will fund support its pipeline of IBD drug candidates for specific patient subpopulations.